TY - JOUR
T1 - Tricyclic antidepressant plasma levels and adverse effects after overdose
AU - Petit, James M.
AU - Spiker, Duane G.
AU - Ruwitch, Joseph F.
AU - Ziegler, Vincent E.
AU - Weiss, Alan N.
AU - Biggs, John T.
PY - 1977/1
Y1 - 1977/1
N2 - Forty patients ingesting tricyclic antidepressant (TAD) overdoses were studied as a pharmacologic model to determine whether total tricyclic antidepressant plasma levels correlated with major adverse effects and electrocardiographic findings. Maximum TAD plasma levels were higher in patients who died (p < 0.025) or had cardiac arrest (p < 0.02), needed respiratory support (p < 0.005), were unconscious (p < 0.02), had grand mal seizures (p < 0.001), ventricular rate ≥ 120/min (p < 0.01), cardiac arrhythmia (p < 0.05), QRS duration ≥ 100 msec (p < 0.001), or bundle branch block (p < 0.05). TAD plasma levels correlated with the dose ingested by history (N = 29, r = 0.58, p < 0.001). Measurement of total TAD (free and protein-bound) appears to correlate well with biologic response.
AB - Forty patients ingesting tricyclic antidepressant (TAD) overdoses were studied as a pharmacologic model to determine whether total tricyclic antidepressant plasma levels correlated with major adverse effects and electrocardiographic findings. Maximum TAD plasma levels were higher in patients who died (p < 0.025) or had cardiac arrest (p < 0.02), needed respiratory support (p < 0.005), were unconscious (p < 0.02), had grand mal seizures (p < 0.001), ventricular rate ≥ 120/min (p < 0.01), cardiac arrhythmia (p < 0.05), QRS duration ≥ 100 msec (p < 0.001), or bundle branch block (p < 0.05). TAD plasma levels correlated with the dose ingested by history (N = 29, r = 0.58, p < 0.001). Measurement of total TAD (free and protein-bound) appears to correlate well with biologic response.
UR - http://www.scopus.com/inward/record.url?scp=0017329482&partnerID=8YFLogxK
U2 - 10.1002/cpt197721147
DO - 10.1002/cpt197721147
M3 - Article
C2 - 832448
AN - SCOPUS:0017329482
SN - 0009-9236
VL - 21
SP - 47
EP - 51
JO - Clinical pharmacology and therapeutics
JF - Clinical pharmacology and therapeutics
IS - 1
ER -